RA0140

antibody from Oursmab

Targeting: CEACAM6 CD66c, NCA

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0140

Provider

Oursmab

Product name

Tinurilimab (Biosimilar Reference Antibody) (CEACAM6)

Antibody type

Monoclonal

Description

Tinurilimab is a humanized IgG2 kappa monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), a glycoprotein overexpressed in many epithelial cancers. It binds to CEACAM6 to block its immunosuppressive function, which normally inhibits effector T cell activity in the tumor microenvironment. It is being developed as an immunomodulatory therapy for CEACAM6-positive solid tumors, such as pancreatic, lung, and colorectal cancers.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.